5,327 Agilent Technologies, Inc. $A Shares Sold by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 74.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,818 shares of the medical research company’s stock after selling 5,327 shares during the quarter. UNIVEST FINANCIAL Corp’s holdings in Agilent Technologies were worth $313,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of A. Signature Equity Partners LLC raised its position in shares of Agilent Technologies by 172.7% in the 3rd quarter. Signature Equity Partners LLC now owns 180 shares of the medical research company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies in the third quarter worth $32,000. Markowski Investments bought a new stake in shares of Agilent Technologies in the second quarter worth $27,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Agilent Technologies in the second quarter worth $31,000. Finally, Osterweis Capital Management Inc. acquired a new stake in Agilent Technologies in the second quarter valued at $43,000.

Agilent Technologies Stock Performance

Shares of A opened at $173.19 on Friday. The stock has a market capitalization of $48.83 billion, a PE ratio of 34.09, a price-to-earnings-growth ratio of 2.59 and a beta of 1.24. The business’s fifty day moving average price is $167.93 and its 200 day moving average price is $138.00. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $182.99.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were issued a $0.2550 dividend. The ex-dividend date of this dividend was Tuesday, October 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. Agilent Technologies’s payout ratio is 20.08%.

Insider Activity at Agilent Technologies

In related news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director owned 4,924 shares of the company’s stock, valued at $745,395.12. This represents a 11.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Analyst Ratings Changes

A number of research firms have commented on A. Wells Fargo & Company increased their price objective on shares of Agilent Technologies from $160.00 to $180.00 and gave the company an “overweight” rating in a research note on Friday, August 28th. The Goldman Sachs Group upped their target price on shares of Agilent Technologies from $175.00 to $185.00 and gave the company a “buy” rating in a research note on Monday, September 21st. JPMorgan Chase & Co. increased their price target on shares of Agilent Technologies from $190.00 to $195.00 in a research report on Wednesday, October 14th. Barclays lifted their price target on Agilent Technologies from $175.00 to $195.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th. Finally, Citigroup boosted their price objective on Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $181.45.

Agilent Technologies Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.